Ocular Therapeutix (OCUL) Inventory Average (2014 - 2026)
Ocular Therapeutix (OCUL) posted quarterly Inventory Average of $3.8 million for Q2 2026, up 19.9% year-over-year from $3.2 million in Q2 2025, and up 3.59% on a QoQ basis from $3.7 million in Q1 2026.
Ocular Therapeutix (OCUL) Inventory Average (2014 - 2026) Analysis & Trends
Ocular Therapeutix has reported Inventory Average for 13 years, with the latest figure at $3.8 million in Q2 2026.
- Inventory Average for Q2 2026 came in at $3.8 million, up 19.9% year-over-year; the trailing twelve-month figure through Jun 2026 was $3.8 million (up 19.9% YoY), and the FY2025 annual result was $3.3 million, up 23.55% from the prior year.
- Inventory Average climbed to $3.8 million in Q2 2026, from $3.7 million in the prior quarter.
- Over five years, Inventory Average peaked at $3.8 million in Q2 2026 and troughed at $1.3 million in Q1 2022.
- A 5-year average of $2.5 million and a median of $2.5 million in 2024 frame the typical range for Inventory Average.
- The widest annual swing landed in 2023, when Inventory Average surged 62.58%; it then gained 11.01% in 2024.
- A 5-year view of Inventory Average shows it stood at $1.8 million in 2022, then advanced by 29.64% to $2.3 million in 2023, then climbed by 19.36% to $2.7 million in 2024, then gained by 29.51% to $3.5 million in 2025, then increased by 7.25% to $3.8 million in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $3.8 million in Q2 2026, $3.7 million in Q1 2026, and $3.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Ocular Therapeutix | 2.20 Bn | 2.20 Bn | 11.46 Mn | 3.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.78 Mn |
| Mar 31, 2026 | 3.65 Mn |
| Dec 31, 2025 | 3.53 Mn |
| Sep 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 3.15 Mn |
| Dec 31, 2024 | 2.72 Mn |
| Sep 30, 2024 | 2.48 Mn |
| Jun 30, 2024 | 2.56 Mn |
| Mar 31, 2024 | 2.44 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 2.23 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 2.12 Mn |
| Dec 31, 2022 | 1.76 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 1.43 Mn |
| Mar 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 1.24 Mn |
| Sep 30, 2021 | 1.17 Mn |